TrialBMC nephrology2019

Randomized, open-label, comparative phase IV study on the bioavailability of Ciclosporin Pro (Teva) versus Sandimmun® Optoral (Novartis) under fasting versus fed conditions in patients with stable renal transplants.

Anja Gäckler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.